Drug-coated balloons are non-inferior to drug-eluting stents for MACE in primary PCI for ST-Elevation Myocardial Infarction patients, but caution is advised for large vessels and in-stent thrombosis.
Do drug-coated balloons reduce or improve MACE compared to drug-eluting stents in STEMI patients undergoing primary PCI?
Drug-coated balloons may offer a non-inferior alternative to drug-eluting stents during primary PCI for STEMI, though caution is warranted in large vessels and in-stent thrombosis.
Absolute Event Rate: 0% vs 0%
Drug-coated balloons appear non-inferior to DES during primary PCI in terms of MACE, including mortality and reinfarction, even in major epicardial coronaries. However, it should be used cautiously in certain lesion subsets, especially large vessels (> 3 mm) and in-stent thrombosis.
Darwish et al. (Fri,) reported a other. Drug-coated balloons are non-inferior to drug-eluting stents for MACE in primary PCI for ST-Elevation Myocardial Infarction patients, but caution is advised for large vessels and in-stent thrombosis.